+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07420400

Testing a New Ultrasound Device to Detect Heart Shunts in Adults Undergoing TEE

Led by Scripps Health · Updated on 2026-02-19

75

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new, battery-powered, non-invasive ultrasound device to detect right-to-left cardiac shunts, specifically patent foramen ovale PFO. The study aims to test how sensitive this novel ultrasound device is compared to the standard clinical method. This observational research is sponsored by Scripps Health and focuses on improving diagnostic approaches for PFO detection. Participants in this study will undergo a clinically indicated transesophageal echocardiogram TEE with a bubble study, which is the current method for detecting PFO. During this procedure, the novel point-of-care ultrasound device will be used to detect microbubbles in the intracranial circulation as an additional diagnostic tool. The study does not involve treatment but focuses on comparing diagnostic techniques during the TEE. Participants will be monitored during the TEE procedure to assess the ultrasound devices performance. The primary outcome is the diagnostic result recorded intraprocedurally during the TEE. Since this is an observational study, there are no treatment visits or long-term follow-up periods. Participation involves undergoing the TEE procedure as part of usual care, with the added use of the ultrasound device for research purposes.

CONDITIONS

Brief Title

Non-Invasive Detection of Right-to-Left Cardiac Shunts

Research Team

M

Matthew J Price, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here